https://psych.global/news-and-insights/ https://psych.global/meet-europes-psychedelic-startups-fuelling-mental-health-innovation/ 2024-04-10T16:13:40+00:00 https://psych.global/psych-symposium-exploring-eating-disorders-and-psychedelics/ 2023-07-05T10:49:11+00:00 https://psych.global/the-future-of-psychedelic-medicine-in-the-eu/ 2023-06-21T16:58:54+00:00 https://psych.global/profiles-ketamine/ 2023-06-21T01:18:47+00:00 https://psych.global/what-to-expect-at-psych-symposium-london-2023/ 2023-05-24T13:47:36+00:00 https://psych.global/profile-psilocybin/ 2023-05-17T17:44:46+00:00 https://psych.global/mdma-profile/ 2023-05-10T15:31:52+00:00 http://psych.global/wp-content/uploads/2022/01/Infographic-Assets-2-06.jpg http://psych.global/wp-content/uploads/2022/01/Screen-Shot-2022-01-05-at-7.27.49-AM.png https://psych.global/accessing-psilocybin-in-the-uk/ 2023-05-03T14:21:50+00:00 https://psych.global/psych-symposium-returns-to-the-european-capital-for-psychedelic-healthcare/ 2023-04-20T10:00:22+00:00 https://psych.global/lsd-bicycle-day/ 2023-04-19T15:21:38+00:00 https://psych.global/psychedelic-research/ 2023-04-12T16:51:01+00:00 https://psych.global/psychedelic-medicine-patents/ 2023-04-12T13:35:23+00:00 https://psych.global/the-cure-act-in-illinois/ 2023-03-29T05:21:58+00:00 https://psych.global/iv-formulation-of-psilocin/ 2023-03-22T12:28:35+00:00 https://psych.global/psilocybin-therapy-in-the-treatment-of-methamphetamine-and-opioid-use-disorders/ 2023-03-15T11:15:07+00:00 https://psych.global/cost-benefit-of-mdma-assisted-therapy/ 2023-02-22T05:57:42+00:00 https://psych.global/harmful-gambling/ 2023-02-20T08:46:03+00:00 https://psych.global/the-rescheduling-of-psychedelic-medicines-in-australia/ 2023-02-08T15:39:08+00:00 https://psych.global/tryp-binge-eating/ 2023-02-03T18:58:58+00:00 https://psych.global/the-future-of-psychedelic-healthcare/ 2023-01-25T21:07:35+00:00 http://psych.global/wp-content/uploads/2022/10/Screen-Shot-2022-10-25-at-8.26.10-AM.png http://psych.global/wp-content/uploads/2021/10/C-01.png http://psych.global/wp-content/uploads/2021/12/Professor-02.png http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-07-at-6.56.18-AM.png http://psych.global/wp-content/uploads/2023/01/Screen-Shot-2023-01-26-at-5.00.36-AM.png https://psych.global/kevin-lorenz/ 2023-01-19T17:34:38+00:00 https://psych.global/atai-shares/ 2023-01-10T16:05:21+00:00 https://psych.global/the-psychedelics-newsletter-in-2022/ 2023-01-04T16:59:02+00:00 http://psych.global/wp-content/uploads/2022/08/Doug-02-1536x864-1.png http://psych.global/wp-content/uploads/2022/10/Screen-Shot-2022-10-25-at-8.26.10-AM.png http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-07-at-6.56.18-AM.png http://psych.global/wp-content/uploads/2022/12/Kabir-Nath.jpeg https://psych.global/beckley-psytech-5-meo-dmt/ 2023-01-03T05:00:52+00:00 https://psych.global/2022-six-significant-inflection-points-in-psychedelic-healthcare/ 2022-12-14T16:54:50+00:00 http://psych.global/wp-content/uploads/2022/09/Screen-Shot-2022-09-28-at-6.54.55-AM.png http://psych.global/wp-content/uploads/2022/04/Rob_Twitter.jpg http://psych.global/wp-content/uploads/2022/09/Screen-Shot-2022-09-07-at-12.49.15-PM.png https://psych.global/compass-pathways-2023/ 2022-12-08T17:28:55+00:00 https://psych.global/blog-psychedelics-as-medicine-report-fourth-edition/ 2022-11-30T15:19:45+00:00 http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-24-at-9.44.24-AM.png http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-24-at-9.48.19-AM.png http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-24-at-9.44.01-AM.png https://psych.global/apex-labs/ 2022-11-23T13:17:29+00:00 https://psych.global/emerging-innovations/ 2022-11-15T15:45:52+00:00 http://psych.global/wp-content/uploads/2022/10/Screen-Shot-2022-10-26-at-6.24.45-AM.png http://psych.global/wp-content/uploads/2022/08/Doug-02-1536x864-1.png https://psych.global/natural-medicine-health-act/ 2022-11-11T14:51:27+00:00 https://psych.global/medical-psychedelic-technical-advisory-board/ 2022-11-09T16:11:45+00:00 http://psych.global/wp-content/uploads/2022/11/Screen-Shot-2022-11-07-at-7.02.23-AM.png https://psych.global/eemerging-innovations-in-psychedelic-healthcare/ 2022-11-02T15:03:12+00:00 https://psych.global/small-pharma-george-tziras/ 2022-10-26T14:19:57+00:00 https://psych.global/innovation-passport/ 2022-10-25T15:26:45+00:00 https://psych.global/washingtons-senate-bill-5660/ 2022-10-19T17:42:57+00:00 http://psych.global/wp-content/uploads/2022/09/Screen-Shot-2022-09-07-at-12.49.15-PM.png https://psych.global/dr-ben-sessa-therapist-training/ 2022-09-28T15:43:18+00:00 https://psych.global/biocase/ 2022-09-21T12:53:04+00:00 https://psych.global/double-blind-randomised/ 2022-09-14T13:51:04+00:00 https://psych.global/oregon-psilocybin-services-angela-allbee/ 2022-09-07T13:26:26+00:00 https://psych.global/the-shoulders-of-the-shulgins/ 2022-08-31T13:29:44+00:00 http://psych.global/wp-content/uploads/2022/08/Doug-02-1536x864-1.png http://psych.global/wp-content/uploads/2022/04/Rob_Twitter.jpg http://psych.global/wp-content/uploads/2022/08/Screen-Shot-2022-08-31-at-10.31.22-AM.png https://psych.global/the-power-of-bipartisan-support/ 2022-08-31T10:10:08+00:00 http://psych.global/wp-content/uploads/2022/08/Untitled-design-62.png https://psych.global/the-mental-health-of-children-and-adolescents/ 2022-08-31T10:09:38+00:00 http://psych.global/wp-content/uploads/2022/04/Rob_Twitter.jpg https://psych.global/psilocybin-in-thailand/ 2022-08-31T10:07:51+00:00 http://psych.global/wp-content/uploads/2022/08/Untitled-design-5.jpg https://psych.global/kabir-nath/ 2022-08-17T14:16:13+00:00 https://psych.global/braving-the-bear-market-investment-in-psychedelic-healthcare/ 2022-07-27T14:38:57+00:00 http://psych.global/wp-content/uploads/2022/07/Screen-Shot-2022-07-27-at-7.37.33-AM.png https://psych.global/public-listing-in-psychedelic-healthcare/ 2022-07-20T19:02:33+00:00 https://psych.global/access-to-psilocybin-in-canada/ 2022-07-15T12:09:42+00:00 https://psych.global/eating-disorders-and-psychedelic-healthcare/ 2022-07-13T19:34:06+00:00 http://psych.global/wp-content/uploads/2022/06/Screen-Shot-2022-03-18-at-7.34.15-AM.png http://psych.global/wp-content/uploads/2022/06/Rob-02-1536x864-1.png https://psych.global/training-psychedelic-therapists/ 2022-07-13T19:33:37+00:00 http://psych.global/wp-content/uploads/2022/07/Untitled-design-57.png https://psych.global/kernel-flow-kernel/ 2022-06-29T14:29:53+00:00 https://psych.global/psych-capital-plc-lists-on-the-aquis-stock-exchange/ 2022-06-15T18:54:33+00:00 https://psych.global/psychedelic-assisted-therapy-at-home/ 2022-06-08T20:34:19+00:00 http://psych.global/wp-content/uploads/2021/07/Ronan-01.png https://psych.global/oregons-psilocybin-services-act/ 2022-05-31T15:48:43+00:00 http://psych.global/wp-content/uploads/2022/05/P1344560.jpg https://psych.global/ceruvia-lifesciences-on-lsd-and-bol-148/ 2022-05-24T12:53:50+00:00 https://psych.global/the-inaugural-psych-symposium/ 2022-05-18T20:54:03+00:00 http://psych.global/wp-content/uploads/2022/05/Screen-Shot-2022-05-18-at-11.26.13-AM.png http://psych.global/wp-content/uploads/2022/05/Screen-Shot-2022-05-18-at-11.40.40-AM.png http://psych.global/wp-content/uploads/2022/05/Screen-Shot-2022-05-18-at-11.25.56-AM.png http://psych.global/wp-content/uploads/2022/05/Screen-Shot-2022-05-18-at-11.27.08-AM.png https://psych.global/a-look-ahead-to-psych-symposium-in-london/ 2022-05-10T13:15:07+00:00 https://psych.global/biomind-labs-relocation-to-the-uk/ 2022-05-10T11:39:50+00:00 https://psych.global/negev-capital-and-investing-in-psychedelic-healthcare/ 2022-05-04T14:47:56+00:00 https://psych.global/mindmed-mm-120-and-dynamic-drug-development/ 2022-04-27T14:21:28+00:00 https://psych.global/bicycle-day/ 2022-04-20T14:04:09+00:00 https://psych.global/mental-health-and-psychedelic-medicine/ 2022-04-13T09:08:51+00:00 https://psych.global/naturally-extracted-psychedelic-medicines/ 2022-04-06T13:47:44+00:00 http://psych.global/wp-content/uploads/2022/04/PXL_20220314_160759526.PORTRAIT.jpg http://psych.global/wp-content/uploads/2022/04/FPSRSwjWYAgkg4x-1.jpeg https://psych.global/compass-pathways-and-comp360-psilocybin-therapy/ 2022-04-04T17:06:50+00:00 https://psych.global/psilocybin-in-the-uk/ 2022-03-23T13:37:55+00:00 https://psych.global/major-depressive-disorder-small-pharma/ 2022-03-21T13:53:48+00:00 https://psych.global/exclusive-novamind-to-host-phase-ii-psilocybin-trial/ 2022-03-09T15:19:45+00:00 https://psych.global/psychedelic-healthcare-and-ptsd/ 2022-03-02T20:16:39+00:00 http://psych.global/wp-content/uploads/2022/03/Keith-Abraham-symposium-twitter.png http://psych.global/wp-content/uploads/2022/02/PSYCH_Symposium_Venue_assets_02_PSYCH_Venue_01-Twitter-copy-5-1.png https://psych.global/patenting-psychedelic-medicines/ 2022-02-23T15:13:14+00:00 http://psych.global/wp-content/uploads/2021/12/f0f649ec-d096-c88c-3c9e-ec801eefed56.jpeg https://psych.global/psych-symposium-2022/ 2022-02-16T22:18:24+00:00 http://psych.global/wp-content/uploads/2022/02/Cosmo-02-1536x864-1.png http://psych.global/wp-content/uploads/2021/12/Growth-of-market-revenues.png http://psych.global/wp-content/uploads/2022/02/PSYCH_Symposium_Venue_assets_02_PSYCH_Venue_01-Twitter-copy-5-1.png https://psych.global/cybin-on-converting-psychedelic-molecules/ 2022-02-09T19:40:23+00:00 https://psych.global/psychedelic-profiles-lsd/ 2022-02-02T19:05:19+00:00 http://psych.global/wp-content/uploads/2022/02/Screen-Shot-2022-02-02-at-9.45.05-AM.png http://psych.global/wp-content/uploads/2022/02/Screen-Shot-2022-02-02-at-9.41.50-AM-1.png https://psych.global/psychedelic-profiles-ibogaine/ 2022-01-26T17:39:27+00:00 http://psych.global/wp-content/uploads/2022/01/Infographic-Assets-2-10-1.jpg http://psych.global/wp-content/uploads/2022/01/Screen-Shot-2022-01-05-at-7.27.49-AM.png http://psych.global/wp-content/uploads/2021/12/Screen-Shot-2021-12-28-at-8.34.09-AM.png https://psych.global/psychedelic-profiles-ketamine/ 2022-01-20T15:25:55+00:00 http://psych.global/wp-content/uploads/2022/01/FIb2ZiRVQAIJnQv.jpeg https://psych.global/psychedelic-profiles-psilocybin/ 2022-01-11T14:55:36+00:00 http://psych.global/wp-content/uploads/2022/01/Infographic-Assets-2-02.jpg http://psych.global/wp-content/uploads/2022/01/Infographic-Assets-12.jpg https://psych.global/psychedelic-profiles-mdma/ 2022-01-06T16:50:54+00:00 http://psych.global/wp-content/uploads/2022/01/Infographic-Assets-2-06.jpg http://psych.global/wp-content/uploads/2022/01/Ben-Sessa-LinkedIn.png http://psych.global/wp-content/uploads/2022/01/Screen-Shot-2022-01-05-at-7.27.49-AM.png https://psych.global/psychedelic-healthcare-in-2021/ 2021-12-31T17:58:36+00:00 http://psych.global/wp-content/uploads/2021/12/Screen-Shot-2021-12-28-at-8.34.09-AM.png http://psych.global/wp-content/uploads/2021/12/Rick-Doblin-Linkedin.png http://psych.global/wp-content/uploads/2021/12/Growth-of-market-revenues.png https://psych.global/gwella-on-on-making-microdosing-mainstream/ 2021-12-22T19:21:54+00:00 https://psych.global/healthcare-professionals-perception-of-psychedelic-medicines/ 2021-12-15T14:49:33+00:00 http://psych.global/wp-content/uploads/2021/12/Infographic-Assets-08-1.jpg http://psych.global/wp-content/uploads/2021/12/Infographic-Assets-06-3.jpg http://psych.global/wp-content/uploads/2021/12/Infographic-Assets-10-2.jpg https://psych.global/is-the-nhs-ready-to-embrace-psychedelics-as-medicine/ 2021-12-09T02:26:40+00:00 https://psych.global/minimising-the-cost-of-psychedelic-healthcare-to-maximise-uptake/ 2021-12-07T18:56:46+00:00 https://psych.global/has-psychedelic-research-reached-a-tipping-point/ 2021-12-01T17:19:29+00:00 http://psych.global/wp-content/uploads/2021/12/Screen-Shot-2021-12-01-at-6.12.25-AM-1.png http://psych.global/wp-content/uploads/2021/12/Untitled-design-6.png https://psych.global/psychedelic-healthcare-the-next-five-years/ 2021-11-29T20:09:54+00:00 http://psych.global/wp-content/uploads/2021/11/Infographic-Assets-02.jpg http://psych.global/wp-content/uploads/2021/11/Screen-Shot-2021-11-09-at-10.04.09-AM-1.png http://psych.global/wp-content/uploads/2021/11/Screen-Shot-2021-11-09-at-10.04.26-AM.png https://psych.global/inside-the-uks-campaign-to-reschedule-psilocybin-with-mp-crispin-blunt/ 2021-11-17T17:35:43+00:00 https://psych.global/cybin-ceo-doug-drysdale-on-investor-opportunities-in-psychedelic-healthcare/ 2021-11-05T13:58:54+00:00 https://psych.global/will-the-uk-be-the-first-european-country-to-embrace-psilocybin-assisted-therapy/ 2021-10-27T20:11:42+00:00 http://psych.global/wp-content/uploads/2021/10/alex-tai-zpRBCGplUzM-unsplash.jpg http://psych.global/wp-content/uploads/2021/10/louis-reed-pwcKF7L4-no-unsplash.jpg https://psych.global/numinuss-ceo-payton-nyquvest-on-the-companys-acquisition-strategy/ 2021-10-20T14:39:03+00:00 https://psych.global/small-pharmas-chief-medical-and-scientific-officer-carol-routledge-on-dmts-power-to-treat-major-depressive-disorder/ 2021-10-12T17:06:21+00:00 https://psych.global/the-psychedelics-as-medicine-report-third-edition/ 2021-10-06T13:07:43+00:00 http://psych.global/wp-content/uploads/2021/10/Screen-Shot-2021-10-05-at-3.09.07-PM.png http://psych.global/wp-content/uploads/2021/09/Screen-Shot-2021-10-05-at-2.00.31-PM.png http://psych.global/wp-content/uploads/2021/09/Screen-Shot-2021-10-05-at-2.32.10-PM-1.png http://psych.global/wp-content/uploads/2021/09/Screen-Shot-2021-10-03-at-7.54.40-AM.png https://psych.global/research-briefing-psychedelics-for-neurodegenerative-disorders/ 2021-09-29T13:07:06+00:00 https://psych.global/david-nutt-chief-research-officer-at-awakn-on-the-prohibition-and-potential-of-psychedelics/ 2021-09-22T12:02:21+00:00 https://psych.global/neonminds-president-and-ceo-robert-tessarolo-on-psilocybins-efficacy-in-treating-obesity/ 2021-09-15T14:34:03+00:00 https://psych.global/exclusive-beckley-psytechs-ceo-cosmo-feilding-mellen/ 2021-09-12T12:23:45+00:00 https://psych.global/tryp-therapeutics-ceo-greg-mckee-on-the-next-wave-of-psychedelic-medicines/ 2021-09-08T12:10:20+00:00 https://psych.global/ryah-groups-ceo-gregory-wagner-on-drug-delivery-through-the-internet-of-things/ 2021-09-02T17:54:57+00:00 http://psych.global/wp-content/uploads/2021/08/October_PSYCH_Investor_Summit_05_Twitter_02-1536x864-1.jpeg https://psych.global/psychedelic-assisted-therapy-enhanced-through-vr-technology/ 2021-08-25T09:53:14+00:00 http://psych.global/wp-content/uploads/2021/08/bermix-studio-4ov6VgaiiX0-unsplash.jpg http://psych.global/wp-content/uploads/2021/08/christopher-lemercier-12yvdCiLaVE-unsplash.jpg http://psych.global/wp-content/uploads/2021/08/October_PSYCH_Investor_Summit_05_Twitter_02-1536x864-1.jpeg https://psych.global/overwhelming-majority-of-canadians-support-the-legalisation-of-psilocybin-assisted-therapyover-80-of-canadians-support-the-legalisation-of-psilocybin-assisted-therapyhmnc-brain-health-on-precision-psy/ 2021-08-23T12:57:10+00:00 http://psych.global/wp-content/uploads/2021/08/bret-kavanaugh-MIfUp3FA5ek-unsplash.jpeg http://psych.global/wp-content/uploads/2021/08/Ronan-02-1024x576-1.png https://psych.global/hmnc-brain-health-on-precision-psychiatry-and-psychedelics/ 2021-08-05T10:15:29+00:00 http://psych.global/wp-content/uploads/2021/08/October_PSYCH_Investor_Summit_05_Twitter_02.jpeg https://psych.global/historic-phase-3-mdma-clinical-trial-shows-success-in-chronic-ptsd/ 2021-08-05T10:11:00+00:00 http://psych.global/wp-content/uploads/2021/08/MAPP1-Infographic2.jpeg http://psych.global/wp-content/uploads/2021/08/MAPS-2017-MP12-MT1-Boulder-MDMA_Yellow_Hand_Packet-Bryce-P1080455.jpeg http://psych.global/wp-content/uploads/2021/08/US-healthcare-savings-by-psychedelics-03.jpeg http://psych.global/wp-content/uploads/2021/08/MAPP1-Infographic3.jpeg http://psych.global/wp-content/uploads/2021/08/MAPP1-Infographic6.jpeg http://psych.global/wp-content/uploads/2021/08/MP12-Boulder.png https://psych.global/transformative-medicines-for-mental-health-psych-symposium-highlights/ 2021-08-05T09:34:23+00:00 http://psych.global/wp-content/uploads/2021/08/image2.png http://psych.global/wp-content/uploads/2021/08/image1.png http://psych.global/wp-content/uploads/2021/08/image3.png https://psych.global/digital-therapeutics-and-telehealth-set-to-transform-psychedelic-therapy/ 2021-08-05T09:28:26+00:00 https://psych.global/consumer-attitudes-to-psychedelics-for-mental-health/ 2021-08-05T09:25:55+00:00 http://psych.global/wp-content/uploads/2021/08/UK-and-US-Support-for-legalising-psychedelic-medicines-01.jpeg https://psych.global/innovation-in-psychedelics/ 2021-08-05T09:22:50+00:00 http://psych.global/wp-content/uploads/2021/08/innovaiton-psych-1.jpeg http://psych.global/wp-content/uploads/2021/08/lucas-vasques-9vnACvX2748-unsplash-scaled-e1597844832678.jpeg http://psych.global/wp-content/uploads/2021/08/creators-collective-bA9zJ1BxJgE-unsplash.jpeg http://psych.global/wp-content/uploads/2021/08/jesse-orrico-rmWtVQN5RzU-unsplash.jpeg https://psych.global/legal-psychedelic-therapies-will-offer-healthcare-cost-savings-of-billions-of-dollars/ 2021-08-05T09:11:38+00:00 http://psych.global/wp-content/uploads/2021/08/US-healthcare-savings-by-psychedelics-01.jpeg http://psych.global/wp-content/uploads/2021/08/Europe-healthcare-savings-by-psychedelics-05.jpeg https://psych.global/psych-talks-to-ronan-levy-on-field-trip-going-public/ 2021-08-05T09:07:24+00:00 http://psych.global/wp-content/uploads/2021/08/health-discovery-digital-1.jpeg https://psych.global/compass-pathways-ipo-could-signal-a-prosperous-future/ 2021-08-04T15:04:16+00:00 http://psych.global/wp-content/uploads/2021/08/EkTJ28pXcAArhM-.jpeg http://psych.global/wp-content/uploads/2021/08/Global-clinical-trial-on-psychedelics-01.jpeg https://psych.global/st-vincent-and-the-grenadines-launch-psychedelics-initiative/ 2021-08-04T14:58:34+00:00 https://psych.global/gwella-and-the-untapped-opportunity-in-functional-mushrooms/ 2021-08-04T14:55:36+00:00 http://psych.global/wp-content/uploads/2021/08/Screen-Shot-2020-12-02-at-11.03.52.png http://psych.global/wp-content/uploads/2021/08/Screen-Shot-2020-12-02-at-11.03.29.png https://psych.global/professor-david-nutt-the-therapeutic-use-of-psychedelics/ 2021-08-04T14:48:18+00:00 http://psych.global/wp-content/uploads/2021/01/Screen-Shot-2021-01-20-at-15.56.53.png http://psych.global/wp-content/uploads/2021/01/Screen-Shot-2021-01-20-at-15.58.50.png https://psych.global/project-psilocybin-and-the-future-of-the-psychedelics-industry/ 2021-08-04T14:21:35+00:00 https://psych.global/psychedelics-apps-a-new-wave-in-data-collection-user-experience/ 2021-08-04T14:10:44+00:00 http://psych.global/wp-content/uploads/2021/04/Mind_Cure_Health_Inc__Mind_Cure_Announces_Build_Out_of_Digital_T.jpeg http://psych.global/wp-content/uploads/2021/04/Field_Trip_logo.png http://psych.global/wp-content/uploads/2021/04/Mind_Cure_Health_Inc__Mind_Cure_Announces_Build_Out_of_Digital_T.jpeg https://psych.global/psychedelics-industry-achieves-investment-milestone/ 2021-08-04T13:59:35+00:00 http://psych.global/wp-content/uploads/2021/08/rising-stock-of-psychedelics-02-2.jpeg http://psych.global/wp-content/uploads/2021/08/rising-stock-of-psychedelics-01.jpeg https://psych.global/when-mother-nature-becomes-big-business/ 2021-08-04T13:46:47+00:00 https://psych.global/an-analysis-of-microdosing-psychedelics/ 2021-08-04T13:40:34+00:00 https://psych.global/results-of-major-study-on-impact-of-microdosing-published/ 2021-08-04T13:36:52+00:00 https://psych.global/results-of-global-drug-survey-published/ 2021-08-04T13:34:54+00:00 https://psych.global/first-ketamine-assisted-psychotherapy-clinic-opens-in-the-uk/ 2021-08-04T13:04:30+00:00 https://psych.global/australia-to-provide-15m-to-support-research-into-psychedelic-medicines/ 2021-08-04T12:58:13+00:00 http://psych.global/wp-content/uploads/2021/08/unnamed-1.jpeg https://psych.global/the-horizons-etfs-makes-q1-update/ 2021-08-04T12:51:00+00:00 https://psych.global/rick-doblin-on-35-years-of-maps-opportunities-for-psychedelic-investors-and-the-path-to-creating-a-strong-industry/ 2021-08-04T12:18:56+00:00 https://psych.global/looking-back-on-the-first-psych-investor-summit-europe-asia/ 2021-08-04T12:13:57+00:00 http://psych.global/wp-content/uploads/2021/04/David-Nutt-twitter.png http://psych.global/wp-content/uploads/2021/04/Screen-Shot-2021-04-21-at-9.27.18-AM.png http://psych.global/wp-content/uploads/2021/04/Screen-Shot-2021-04-20-at-1.23.19-PM.png http://psych.global/wp-content/uploads/2021/04/PSYCH-summit-research-and-dev-launching_twitter-02.jpeg https://psych.global/learning-from-the-north-american-psychedelics-market-is-europe-following-in-its-footsteps-or-forging-its-own-path/ 2021-08-04T11:47:36+00:00 http://psych.global/wp-content/uploads/2021/08/Europe-healthcare-savings-by-psychedelics-01.jpeg http://psych.global/wp-content/uploads/2021/08/Screen-Shot-2021-04-20-at-1.23.19-PM.png https://psych.global/continental-focus-psychedelics-in-asia-part-1/ 2021-08-04T10:40:54+00:00 https://psych.global/for-better-or-for-worse-enter-the-psychedelics-celebrity/ 2021-08-04T10:37:53+00:00 http://psych.global/wp-content/uploads/2021/08/MindMedChopra1.jpeg https://psych.global/dr-carl-hart-on-the-impediment-of-prolonged-research/ 2021-08-04T09:55:16+00:00 http://psych.global/wp-content/uploads/2021/05/Drug-Use-For-Grown-Ups.jpeg http://psych.global/wp-content/uploads/2021/05/UK-and-US-support-for-psychedelics-03-1.jpeg https://psych.global/rising-tides-north-american-drug-regulations-and-the-impact-on-big-psychedelic-business-part-1/ 2021-08-04T09:44:51+00:00 https://psych.global/rising-tides-north-american-drug-regulations-and-the-impact-on-big-psychedelic-business-part-2/ 2021-08-04T09:40:32+00:00 https://psych.global/awakn-life-sciences-lists-on-the-neo-exchange/ 2021-08-04T09:35:28+00:00 http://psych.global/wp-content/uploads/2021/06/Screen-Shot-2021-06-23-at-12.23.27-PM.png https://psych.global/psych-investor-summit-research-development-to-highlight-the-latest-in-medical-psychedelic-science-and-investment-opportunities/ 2021-08-04T09:31:28+00:00 http://psych.global/wp-content/uploads/2021/06/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-20.png http://psych.global/wp-content/uploads/2021/06/Rick-Doblin-Christian-Angermayer-Graphic-03.jpeg http://psych.global/wp-content/uploads/2021/06/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-19.png http://psych.global/wp-content/uploads/2021/06/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-18.png http://psych.global/wp-content/uploads/2021/06/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-17.png http://psych.global/wp-content/uploads/2021/06/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-25.png http://psych.global/wp-content/uploads/2021/06/4.png http://psych.global/wp-content/uploads/2021/06/5.png https://psych.global/braxia-scientific-identifies-short-term-roi-in-psychedelic-medicine/ 2021-08-04T09:03:23+00:00 http://psych.global/wp-content/uploads/2021/08/PSYCH-summit-research-and-dev-launching_twitter-copy-2.jpeg https://psych.global/looking-back-on-the-psych-investor-summit-research-development/ 2021-08-04T08:49:54+00:00 http://psych.global/wp-content/uploads/2021/08/photo_2021-07-12-07.07.08.jpeg http://psych.global/wp-content/uploads/2021/08/Panel-Social-Assets-PSYCH-Investor-Summit-R_D-25.png http://psych.global/wp-content/uploads/2021/08/Eventbrite_01-2.jpeg https://psych.global/data-science-driving-innovation-in-psychedelic-medicine/ 2021-07-29T07:58:48+00:00 http://psych.global/wp-content/uploads/2021/07/Blossom_asset_03-2-1536x1536-1.jpeg http://psych.global/wp-content/uploads/2021/07/Blossom_asset_01-1-1-1536x864-1.jpeg http://psych.global/wp-content/uploads/2021/07/Blossom-Assets_3-1536x864-1.jpeg http://psych.global/wp-content/uploads/2021/07/October_PSYCH_Investor_Summit_05_Eventbrite_02-1536x768-1.jpeg https://psych.global/biden-calls-for-lower-drug-prices-should-psychedelics-investors-be-concerned/ 2021-07-28T15:14:43+00:00 http://psych.global/wp-content/uploads/2021/07/Blossom-Assets_15-1-2048x2048-1.jpg http://psych.global/wp-content/uploads/2021/07/hermes-rivera-ahHn48-zKWo-unsplash-2048x1090-1.jpg https://psych.global/exclusive-field-trips-co-founder-and-executive-chairman-ronan-levy-on-investor-opportunities-following-nasdaq-listing/ 2021-07-28T14:38:32+00:00 https://psych.global/tryp-therapeutics-to-treat-psychiatric-disorders-with-synthetic-psilocybin/ 2021-07-28T07:56:06+00:00 http://psych.global/wp-content/uploads/2021/07/hero-img.png https://psych.global/the-trajectory-and-importance-of-psychedelic-clinical-trials/ 2021-07-28T07:55:57+00:00 http://psych.global/wp-content/uploads/2021/07/hero-img.png